Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)
ClinicalTrials.gov study NCT04808999. IPD Sharing: NO. Countries: 1. Publications: 0.
Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC
ClinicalTrials.gov study NCT07086300. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
ClinicalTrials.gov study NCT06870942. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)
ClinicalTrials.gov study NCT04439201. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD
ClinicalTrials.gov study NCT04247594. IPD Sharing: YES. Countries: 1. Publications: 0.
Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
ClinicalTrials.gov study NCT01520649. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
ClinicalTrials.gov study NCT07216066. IPD Sharing: YES. Countries: 1. Publications: 0.
LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma
ClinicalTrials.gov study NCT04577807. IPD Sharing: NO. Countries: 1. Publications: 0.
Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients
ClinicalTrials.gov study NCT01575652. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Instrumental or Physical-Exercise Rehabilitation of Balance in Parkinson's Disease? (IPER-PD)
ClinicalTrials.gov study NCT03314597. IPD Sharing: NO. Countries: 0. Publications: 9.
Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD
ClinicalTrials.gov study NCT00577460. IPD Sharing: Not stated. Countries: 14. Publications: 0.
Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
ClinicalTrials.gov study NCT03737123. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04936841. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
ClinicalTrials.gov study NCT04356729. IPD Sharing: YES. Countries: 1. Publications: 0.
To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)
ClinicalTrials.gov study NCT01033019. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
ClinicalTrials.gov study NCT06246916. IPD Sharing: YES. Countries: 2. Publications: 0.
A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer
ClinicalTrials.gov study NCT03936959. IPD Sharing: NO. Countries: 5. Publications: 0.
Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study
ClinicalTrials.gov study NCT01453023. IPD Sharing: YES. Countries: 1. Publications: 0.
Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer.
ClinicalTrials.gov study NCT03262779. IPD Sharing: NO. Countries: 1. Publications: 0.
TARGTEPO Treatment for Anemia in PD US Trial
ClinicalTrials.gov study NCT02468414. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.